BRIEF published on 11/19/2024 at 07:08, 1 year 2 months ago Siegfried Opens New R&D Center for Drug Substances in Evionnaz Pharmaceutical Industry Siegfried AG Drug Substances R&D Center Evionnaz
PRESS RELEASE published on 11/19/2024 at 07:03, 1 year 2 months ago Siegfried opens new global R&D Center for Drug Substances in Evionnaz Siegfried inaugurates new R&D Center for Drug Substances in Evionnaz, Switzerland, enhancing global development capabilities and supporting EVOLVE+ strategy Pharmaceutical Industry Drug Substances Siegfried R&D Center Evionnaz
BRIEF published on 11/12/2024 at 06:35, 1 year 2 months ago DINAMIQS s'agrandit avec un nouveau laboratoire à Zurich Thérapie Cellulaire Et Génique Bio-Technopark Zurich Laboratoire DINAMIQS Extension Siegfried Fabrication De Vecteurs Viraux
BRIEF published on 11/12/2024 at 06:35, 1 year 2 months ago DINAMIQS Expands with New Lab in Zurich Cell And Gene Therapy DINAMIQS Lab Siegfried Expansion Viral Vector Manufacturing Bio-Technopark Zurich
PRESS RELEASE published on 11/12/2024 at 06:30, 1 year 2 months ago DINAMIQS opens new lab in Zurich Siegfried's subsidiary DINAMIQS opens new state-of-the-art lab in Zurich Bio-Technopark, strengthening offerings in cell and gene therapy market Cell And Gene Therapy Zurich Siegfried DINAMIQS Lab
BRIEF published on 10/24/2024 at 06:35, 1 year 3 months ago Siegfried AG dévoile sa stratégie EVOLVE+ pour une croissance durable Excellence Opérationnelle Développement Stratégique Croissance Pharmaceutique Stratégie EVOLVE+ Agrandissement Du CDMO
BRIEF published on 10/24/2024 at 06:35, 1 year 3 months ago Siegfried AG Unveils EVOLVE+ Strategy for Sustained Growth Operational Excellence Strategic Development Pharmaceutical Growth EVOLVE+ Strategy CDMO Expansion
PRESS RELEASE published on 10/24/2024 at 06:30, 1 year 3 months ago Strategy EVOLVE+ paves the way for continued profitable growth Siegfried unveils EVOLVE+ strategy at Capital Markets Day, focusing on growth, technology, and operational excellence. CEO emphasizes company's strong position in the CDMO market CDMO Strategy Growth Siegfried EVOLVE+
BRIEF published on 09/04/2024 at 06:35, 1 year 5 months ago EGS Beteiligungen AG Increases Stake in Siegfried to 7.2% Registered Shares Convertible Bond Shareholding Increase EGS Beteiligungen AG Pharmaceutical Acquisition Siegfried Holding
BRIEF published on 09/04/2024 at 06:35, 1 year 5 months ago EGS Beteiligungen AG augmente sa participation dans Siegfried à 7,2 % des actions nominatives Obligation Convertible Acquisition Pharmaceutique Siegfried Holding EGS Participations AG Augmentation De La Participation
Published on 02/05/2026 at 15:45, 31 minutes ago American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 1 hour 6 minutes ago Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 1 hour 26 minutes ago High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 14:30, 1 hour 46 minutes ago Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Published on 02/05/2026 at 14:30, 1 hour 46 minutes ago Innodata to Report Fourth Quarter and Fiscal Year 2025 Results
Published on 02/05/2026 at 15:56, 19 minutes ago Original-Research: Verve Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 02/05/2026 at 15:40, 36 minutes ago BIKE24 exceeds revenue and earnings forecast for fiscal year 2025 – strong growth in the fourth quarter
Published on 02/05/2026 at 15:34, 42 minutes ago EQS-Adhoc: Bike24 Holding AG: Preliminary sales and earnings exceed the previous forecast range for the 2025 financial year
Published on 02/05/2026 at 15:15, 1 hour 1 minute ago FIS SUCCESSFULLY COMPLETES €770 MILLION BOND ISSUANCE
Published on 02/05/2026 at 16:04, 12 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 02/05/2026 at 16:02, 13 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Published on 02/05/2026 at 11:30, 4 hours 46 minutes ago Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 4 hours 46 minutes ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 22 hours 12 minutes ago Capital et droits de vote au 31 janvier 2026
